VNDA — Vanda Pharmaceuticals Inc. catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

3 verified catalyst event(s) for Vanda Pharmaceuticals Inc. (ticker VNDA). Each is linked to its official source. Verified as of 2026-11-04.

Next verified catalyst

2026-12-01 — Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social · official source ↗

Upcoming

Date	Event	Company	Drug	Official source & verification
2026-12 (month) in 27d ESTIMATED	READOUT Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment Phase 3 · Social Anxiety Disorder (SAD)	VNDA Vanda Pharmaceuticals Inc.	VQW-765	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2026-12-01 in 27d ESTIMATED	READOUT A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1 Phase 3 · Nausea and Vomiting, Obesity	VNDA Vanda Pharmaceuticals Inc.	Tradipitant	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change
2027-03 (month) in 4mo ESTIMATED	READOUT Treatment of Charcot-Marie-Tooth Disease, Axonal, Type 2S (CMT2S) in an Individu Phase 1/2 · Charcot Marie Tooth Disease (CMT), Neuromuscular Diseases (NMD)	VNDA Vanda Pharmaceuticals Inc.	VCA-894A	ClinicalTrials.gov ↗ ✓ Source-checked 2026-11-04 Sponsor-projected date — can change